openPR Logo
Press release

Insulin Delivery Devices Market : Worldwide Study on Top Players | Eli Lilly, Sanofi, Novo Nordisk, Beckton and Dickenson, Roche, Medtronic, Insulet Corporation and Ypsomed

02-14-2019 11:19 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Insulin Delivery Devices Market

Insulin Delivery Devices Market

Insulin Delivery Devices Market size was valued over USD 12 billion in 2017 and is expected to witness more than 6.5% CAGR from 2018 to 2024.
Increasing demand for insulin delivering devices and minimally invasive alternatives such as pumps, advancements in insulin devices in terms of design and functioning, increasing prevalence of diabetes and ease offered by some insulin delivery devices to patients are some of the major market growth driving factors observed worldwide.

Globally, escalating prevalence of diabetes is the prominent reason behind insulin delivery devices market expansion. Owing to inappropriate eating habits and lack of physical work; diabetes incidences are rising at alarming rates in developing countries too. From the consumer’s side, usage complication and probability of injury due to injections have been resulting in shift from invasive devices to minimally invasive ones. More and more minimally invasive devices are gaining demand around the globe, especially in developed nations.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1649

The insulin delivery devices market faces some peculiar challenges which have been and will continue to be hindering growth during the forecast period. Factors such as high cost of insulin and insulin delivery devices, inconsistencies in adherence of insulin uptake and psychological resistances to self-injection due to needle-phobia are major roadblock in insulin delivery devices market growth.

Low per capita diabetes expenditure, and lack of reimbursement and insurance coverage in emerging economies happen to be significant constraints in industry growth. During the forecast period, high cost of devices will result in slow and low adoption rates, especially in resource poor economies.

U.S. insulin delivery devices market was valued at USD 5.0 billion in 2017 and accounted for regional share of more than 95% in 2017. Increasing diabetes prevalence coupled with rising disposable income level will drive market growth over the forecast period. Technological advances in insulin delivery devices along with favourable government initiatives to execute better diabetes management will further fuel industry growth.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1649

Germany insulin delivery devices market held around 30% of the regional revenue share in 2017. Expanding elderly population base, rising incidence of diabetes, favourable reimbursement policies and increasing disposable incomes will serve as high impact rendering factors.

China insulin delivery devices market was valued at USD 1.1 billion in 2017 and it anticipated to witness around 14% growth over the forecast period. With its huge diabetic population and rapid economic development, the country spends almost USD 25 billion for treating diabetes related diseases annually. However, only about 35% of diabetic population is aware of being diabetic and are receiving treatment for their condition, whereas rest are undiagnosed. Improvement in diagnosis rate and increased awareness towards early diagnosis will drive demand for insulin delivery devices over the forecast period.

Some of the major players of global insulin delivery devices market are Eli Lilly, Sanofi, Novo Nordisk, Beckton and Dickenson, Roche, Medtronic, Insulet Corporation and Ypsomed. Industry players are focusing on new product development to offer superior insulin delivery devices. Geographic expansion is one the major strategies adopted by big companies to gain market share.

Insulin delivery devices industry has been rapidly developing since its inception in late 1970’s; when first insulin pump was manufactured. Post launch of first device, the industry has been through a rapid evolution in terms of increasing number of companies developing new products such as reusable pens, safely needles, etc. Although being in the growth phase, the industry is still witnessing introduction of novel products such as tubeless insulin pumps. Currently, only handful of companies offer tubeless insulin pumps, and many are in process to launch their version of pumps in market in near future.

Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data Sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Insulin delivery devices industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Regional trends
Chapter 3. Insulin Delivery Devices Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Favorable device insurance and reimbursement policies in North America and Europe
3.3.1.2. Collaboration of public and private sectors to meet diabetes needs
3.3.1.3. Growing diabetes burden in Latin American countries
3.3.1.4. Increasing healthcare expenditure in Middle Eastern region
3.3.2. Industry pitfalls & challenges
3.3.2.1. Low usage of insulin pumps in Europe
3.3.2.2. High out-of-pocket expenditure required for diabetes management in Asia Pacific region
3.3.2.3. Limited access to public healthcare and associated high cost in Latin America
3.3.2.4. Stringent government regulations and product approvals in Middle East
3.4. Diabetes prevalence in major countries, 2017
3.4.1. Diabetes prevalence in Euro 5 countries, 2017
3.5. Global cost of diabetes management by region, 2017
3.6. Major company’s product portfolio
3.7. Growth potential analysis
3.7.1. By product
3.8. Regulatory landscape
3.8.1. U.S
3.8.2. Europe
3.9. Reimbursement policies and public healthcare sector insurance coverage
3.10. Company market share
3.11. Competitive landscape, 2017
3.11.1. Business overview
3.11.2. Revenue analysis
3.11.3. Product landscape
3.11.4. Strategy dashboard
3.12. Porter’s analysis
3.13. PESTEL analysis

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Delivery Devices Market : Worldwide Study on Top Players | Eli Lilly, Sanofi, Novo Nordisk, Beckton and Dickenson, Roche, Medtronic, Insulet Corporation and Ypsomed here

News-ID: 1588134 • Views: 261

More Releases from Global Market Insights, Inc.

Hypochlorite Bleaches Market to hit US$ 300 Mn 2025 | Top Key Players like Adity …
As per the research report by Global Market Insights, Inc., Global Hypochlorite Bleaches Market to cross USD 300 million by 2025 and grow at 3.4% CAGR from 2019 to 2025. It has been projected that the Global hypochlorite bleaches market is expected to reach a consumption of around 485-kilo tons by 2025. Water scarcity as well as rising water costs have led to more emphasis being laid on water recycling and
Feminine Hygiene Products Market: Growing awareness regarding intimate health in …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Feminine Hygiene Products Market. One of the most hushed topics across the world is female hygiene, the negligence of which results in several diseases. Studies claim that nearly 30% to 60 % women across the globe develop urinary tract infection once in their lifetime, mainly due to negligence in proper intimate hygiene. Dearth of knowledge regarding the negative consequences of
Examination Gowns Market 2020 business trends & growth opportunities to 2026
Global Market Insights, Inc., announces an ongoing comprehensive report on the Examination Gowns Market. The exposure to various kinds of hospital acquired infections has led to a spate of health problems for the healthcare professionals as well has the patients. In this regard, experts have been massively shifting to adoption of personal protective equipment or clothing, examination gowns, protecting them from all kinds of infections. These gowns are present in the
Nonwoven Packaging Market to witness increased demand from pharmaceutical sector …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Nonwoven Packaging Market. With the world struggling to fight against negative consequences of industrialization and increased carbon emissions, nonwovens or nonwoven fabrics have emerged as an intrinsic solution for all ecological imbalances across the globe. These fabrics are made from staple fiber and long fibers, merged together by chemical, heat, or mechanical treatment. These are generally used in textile manufacturing

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact
Global Insulin Delivery Machine Market: By Types - Insulin Pens, Insulin Pumps, …
Latest industry research report on: Global Insulin Delivery Machine Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1181480 This report studies Insulin Delivery Machine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in